Dr. Helen Mulol obtained her PhD in Paediatrics from the University of KwaZulu-Natal. Her research involved a longitudinal study of breast milk intake volumes and maternal and infant body composition in the first year of the infant’s life using a stable isotope technique, which also enables objective determination of exclusive breastfeeding. Since graduating, she has been involved in child health care research. She joined the University of Pretoria’s Research Centre for Maternal, Fetal, Newborn and Child Health Care Strategies to work as Principal Investigator for the UmbiBaby study in 2019. The UmbiBaby study is following up some of the infants from the South African site of the UmbiflowTM international study, which is a multi-country study that monitored infants for growth-restriction due to placental insufficiency using the novel UmbiflowTM device. Growth, body composition and neurological development of the infants over the first two years of life are the major outcomes of the UmbiBaby study, which aims to also provide further information regarding the management of infants after birth who were found to be growth-restricted in utero.